PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses02Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses03Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses04Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses05Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses06Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses07Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses08Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses09Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneOperatingExpenses10Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue02Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue03Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults02Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults03Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets02Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets03Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2020-06-30in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2020-04-012020-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PERSISTENT 2020-04-01 2021-03-31 2020-06-22 INR Millions First quarter Multi segment 2020-04-01 2020-06-30 Audited Consolidated 9913850000.00 212270000.00 10126120000.00 0.00 0.00 0.00 7135540000.00 14160000.00 435610000.00 1320370000.00 8905680000.00 1220440000.00 0.00 1220440000.00 439060000.00 -118700000.00 320360000.00 0.00 900080000.00 0.00 0.00 0.00 0.00 900080000.00 236270000.00 1136350000.00 900080000.00 0.00 1136350000.00 0.00 764250000.00 10 11.78 11.78 0.00 0.00 11.78 11.78 0.00 Notes: n n1. The audited condensed interim consolidated financial statements for the quarter ended June 30, 2020, have been taken on record by the Board of Directors at its meeting concluded on July 25, 2020 as recommended by the Audit Committee. The statutory auditors have expressed an unqualified audit opinion. The information presented above is extracted from the audited condensed interim consolidated financial statements. n n2. The Group has considered the possible effects that may result from COVID-19 in the preparation of these condensed interim consolidated financial statements including the recoverability of carrying amounts of financial and non financial assets. In developing the assumptions relating to the possible future uncertainties in the global economic conditions because of COVID-19, the Group has, at the date of approval of these condensed interim consolidated financial statements, used internal and external sources of information including internal credit evaluation report and related information and economic forecasts and expects that the carrying amount of these assets will be recovered. The impact of COVID-19 on the Group's condensed interim consolidated financial statements may differ from that estimated as at the date of approval of these condensed interim consolidated financial statements. n n3. During the quarter, there were 641 shareholders who were eligible to receive aggregate amount of INR 2,00,865 towards 2nd Interim Dividend for the Financial Year 2019-20 through Dividend Warrants. However, due to lockdown restrictions on account of COVID-19 pandemic, it was difficult for the Group to make necessary arrangements. Therefore, in the interest of time, the Group paid the above dividend amount to these shareholders through Demand Drafts. n n4. Mr. Prakash Telang and Mr. Kiran Umrootkar, Independent Directors of the Company retired at the 30th Annual General Meeting of the Company held on July 24, 2020. n n5. Valista Limited, Ireland, the wholly owned subsidiary of the Company has been voluntarily dissolved w.e.f. June 24, 2020 n n6. The investors are requested to visit the following website of the Group and Stock Exchanges for further details: n•tGroup's website: nhttps://www.persistent.com/investors n•tBSE Ltd: www.bseindia.com n•tNational Stock Exchange of India Ltd.: www.nseindia.com n nNotes on ratios: n n1. Debt Equity is computed as Debt / (Share Capital + Other Equity) n2. Debt service ratio is at 431. Annualised. (EBITDA/Debt service for a year) n3. Interest service ratio is at 11045. Annualised. (EBIT/Interest service for a year) Communication expenses 26720000.00 Donations 95430000.00 Internet link expenses 26760000.00 Legal and professional fees 111480000.00 Other Expenses 235460000.00 Provision for doubtful receivables (net) 53100000.00 Purchase of software licenses 631600000.00 Recruitment expenses 20760000.00 Rent 39710000.00 Travelling and conveyance 79350000.00 - BFSI 3153110000.00 - Healthcare & Life Sciences 1957470000.00 - Technology companies and Emerging Verticals 4803270000.00 9913850000.00 0.00 9913850000.00 - BFSI 1049050000.00 - Healthcare & Life Sciences 899430000.00 - Technology companies and Emerging Verticals 1587940000.00 3536420000.00 14160000.00 2301820000.00 1. Considering the focus on industry verticals, the Group has decided to reorganize it’s operating segments from April 1, 2020. The figures for the corresponding periods/year have been appropriately reclassified in line with the current period classification. n nThe operating segments are: na. Banking, Financial Services and Insurance (BFSI) nb. Healthcare & Life Sciences nc. Technology companies and Emerging Verticals n n n2. Note for segment wise information: nOperating segments are components of an enterprise for which discrete financial information is available that is evaluated regularly by the chief operating decision makers, in deciding how to allocate resources and assessing performance. The Group's chief operating decision makers are the Chief Executive Officer and the Chairman. n n3. Segment wise capital employed nSegregation of assets (other than trade receivables), liabilities, depreciation and amortization and other non-cash expenses into various reportable segments have not been presented as the assets and liabilities are used interchangeably between segments and the Group is of the view that it is not practical to reasonably allocate the other assets, liabilities and other non-cash expenses to individual segments and an ad-hoc allocation will not be meaningful. 1220440000.00 - BFSI 2059460000.00 - Healthcare & Life Sciences 1547620000.00 - Technology companies and Emerging Verticals 3134890000.00 6741970000.00 25434370000.00 32176340000.00 - BFSI 0.00 - Healthcare & Life Sciences 0.00 - Technology companies and Emerging Verticals 0.00 0.00 32176340000.00 32176340000.00